Comparison of Propofol Deep Sedation Versus Moderate Sedation During Endosonography
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The purposes of this study are: (1) to prospectively evaluate clinically relevant outcomes including sedation-related complications for endoscopic ultrasound (EUS) procedures performed with the use of propofol deep sedation administered by monitored anesthesia care (MAC), and (2) to compare these results with a historical case–control cohort of EUS procedures performed using moderate sedation provided by the gastrointestinal (GI) endoscopist.
Materials And Methods
Patients referred for EUS between January 1, 2001 and December 31, 2002 were enrolled. Complication rates for EUS using MAC sedation were observed and also compared with a historical case–control cohort of EUS patients who received meperidine/midazolam for moderate sedation, administered by the GI endoscopist. Logistic regression analysis was used to isolate possible predictors of complications.
A total of 1,000 patients underwent EUS with propofol sedation during the period from January 1, 2001 through December 31, 2002 (mean age 64 years, 53% female). The distribution of EUS indications based on the primary area of interest was: 170 gastroduodenal, 92 anorectal, 508 pancreaticohepatobiliary, 183 esophageal, and 47 mediastinal. The primary endpoint of the study was development of sedation-related complications occurring during a performed procedure. A total of six patients experienced complications: duodenal perforation (one), hypotension (one), aspiration pneumonia (one), and apnea requiring endotracheal intubation (three). The complication rate with propofol was 0.60%, compared with 1% for the historical case–control (meperidine/midazolam moderate sedation) group.
There does not appear to be a significant difference between complication rates for propofol deep sedation with MAC and meperidine/midazolam administered for moderate sedation.
- Astra Zeneca Diprivan prescriber information package, July 2004.
- Rex D, Overley C, Kinser K, et al. Safety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic cases. Am J Gastroenterol. 2002;97(5):1159–1163. CrossRef
- Horiuchi A, Nakayama Y, Katsuyama Y, et al. Safety and driving ability following low dose propofol sedation. Digestion. 2008;78:190–194. CrossRef
- Vargo J, Zuccaro G, Dumot J, et al. Gastroenterologist-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: a case series. Gastrointest Endosc. 2000;52(2):250–255. CrossRef
- Weston B, Chadalawada V, Chalasani N, et al. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. Am J Gastroenterol. 2003;98(11):2440–2447. CrossRef
- Cordruwisch W, Doroschko M, Wurbs D. Deep sedation in gastrointestinal endoscopic interventions: safety and reliability of a combination of midazolam and propofol. Dtsch Med Wochenschr. 2000;125(20):619–622. CrossRef
- Vargo J, Zuccaro G, Dumot J, et al. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial. Gastroenterology. 2002;123(1):8–16. CrossRef
- Benjamin S. Complications of moderate sedation. Gastrointest Endosc Clin North Am. 1996;6(2):277–286.
- Heuss L, Schnieper P, Drewe J, et al. Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases. Gastrointest Endosc. 2003;57:664–671. CrossRef
- Sipe B, Rex D, Latinovich D, et al. Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointest Endosc. 2002;55(7):815–825. CrossRef
- Kulling D, Fantin A, Biro P, et al. Safer colonoscopy with patient-controlled analgesia and sedation with propofol and alfentanil. Gastrointest Endosc. 2001;54(1):1–7. CrossRef
- Nelson D, Barkun A, Block K, et al. Propofol use during gastrointestinal endoscopy. Gastrointest Endosc. 2001;53(7):876–879.
- Wehrmann T, Kokabpick S, Lembcke B, et al. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc. 1999;49:677–683. CrossRef
- Cote GA, Hovis RM, Ansstas MA, Waldbaum L, Azar RR, Early DS, Edmundowicz SA, Mullady DK, Jonnalagadda SS. Incidence of sedation-related complications with propofol use during advanced endoscopic procedures. Clin Gastroenterol Hepatol. 2009; (Epub ahead of print).
- Chak A, Cooper G. Procedure-specific outcomes assessment for endoscopic ultrasonography. Gastrointest Endosc. 1999;9(4):649–656.
- Gress F, Schmitt C, Sherman S, et al. Endoscopic ultrasound-guided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience. Am J Gastroenterol. 2001;96(2):409–416. CrossRef
- Faigel DO, Eisen GM, Baron TH, et al. Standards of practice committee. American society for gastrointestinal endoscopy. Preparation of patients for GI endoscopy. Gastrointest Endosc. 2003;57(4):446–450. CrossRef
- Faigel DO, Baron TH, Goldstein JL, et al. Standards practice committe, American society for gastrointestinal endoscopy. Guidelines for the use of deep sedation and anesthesia for GI endoscopy. Gastrointest Endosc. 2002;56(5):613–617. CrossRef
- Koshy G, Nair S, Norkus E. Propofol versus midazolam and meperidine for moderate sedation in GI endoscopy. Am J Gastroenterol. 2001;95(6):1476–1479. CrossRef
- Dewitt J, McGreevy K, Sherman S, Imperiale TF. Nurse-administered propofol sedation compared with midazolam and meperidine for EUS: a prospective, randomized trial. Gastrointest Endosc. 2008;68(3):499–509. CrossRef
- Wehrmann T, Riphaus A. Sedation with propofol for interventional endoscopic procedures: a risk factor analysis. Scand J Gastroenterol. 2008;43(3):368–374. CrossRef
- Walker J, Schleinitz P, Jacobson K, et al. Propofol: Multiple advantages for endoscopy and colonoscopy in 1424 consecutive patients. Gastrointest Endosc. 2000;51(4):AB59.
- Khanna S, Tobin R, Khare S, et al. Propofol- a safe and effective sedative for endoscopy. Indian J Gastroenterol. 2003;22:56–58.
- Graber R. Propofol in the endoscopy suite: an anesthesiologist’s perspective. Gastrointest Endosc. 1999;49:803–806. CrossRef
- Dubois A, Balatoni E, Peeters J, et al. Use of propofol for sedation during gastrointestinal endoscopies. Anaesthesia. 1998;43(suppl):75–80.
- Comparison of Propofol Deep Sedation Versus Moderate Sedation During Endosonography
Digestive Diseases and Sciences
Volume 55, Issue 9 , pp 2537-2544
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Endoscopic ultrasound
- Deep sedation
- Industry Sectors
- Author Affiliations
- 1. Gastroenterology Associates of Central Jersey, Edison, NJ, USA
- 4. Division of Gastroenterology, SUNY-Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY, 11203, USA
- 2. Department of Biostatistics, Winthrop University Hospital, Mineola, NY, USA
- 3. Department of Anesthesiology, Winthrop University Hospital, Mineola, NY, USA